Frontiers in Neurology | Multiple Sclerosis and Neuroimmunology

Original Research

Accepted on 04 Jun 2025

Cladribine tablets as therapy for advanced relapsing-remitting multiple sclerosis: a 4-year follow-up real-world, multi-center, retrospective, cohort study

in Multiple Sclerosis and Neuroimmunology

Aleksandra Pogoda-Wesołowska
Adam Stepien
Marcin Wnuk
Monika Marona
Elżbieta Tokarz-Kupczyk
Karolina Piasecka-Stryczyńska
Konrad Rejdak
Anna Jamroz- Wiśniewska
Monika Adamczyk-Sowa
Katarzyna Kubicka-Bączyk

Frontiers in Neurology

doi 10.3389/fneur.2025.1626317

244 views

Original Research

Accepted on 02 Jun 2025

Autoantibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with psychotic symptoms

in Multiple Sclerosis and Neuroimmunology

Nikita A. van de Burgt
Laila Kulsvehagen
Marina Mané Damas
Luc Lutz
Anne-Catherine Lecourt
Clara Montserrat
Anita Vinke
Cem I Küçükali
Shenghua Zong
Carolin Correia-Hoffmann

Frontiers in Neurology

doi 10.3389/fneur.2025.1593042

187 views

Systematic Review

Published on 30 May 2025

A narrative review of the economic burden of myelin oligodendrocyte glycoprotein antibody-associated disease and analogous conditions

in Multiple Sclerosis and Neuroimmunology

Leonard Lee
Joshua Byrnes
Cathryn Hope
Hansoo Kim

Frontiers in Neurology

doi 10.3389/fneur.2025.1506465

634 views

Original Research

Published on 29 May 2025

Progression independent of relapsing biology in multiple sclerosis: a real-word study

in Multiple Sclerosis and Neuroimmunology

Heather Y. F. Yong
Carlos Camara-Lemarroy

Frontiers in Neurology

doi 10.3389/fneur.2025.1595929

466 views

Original Research

Accepted on 26 May 2025

Impact of visual discomfort symptoms on SDMT performance among persons with MS

in Multiple Sclerosis and Neuroimmunology

Michelle Chen
Timothy Rich
Nancy D Chiaravalloti
Yael Goverover
Silvana L Costa

Frontiers in Neurology

doi 10.3389/fneur.2025.1569451

152 views

Original Research

Published on 21 May 2025

CONFIDENCE treatment success: long-term real-world effectiveness and safety of ocrelizumab in Germany

in Multiple Sclerosis and Neuroimmunology

Mathias Buttmann
Martin S. Weber
Sven G. Meuth
Sandra Blümich
Stefanie Hieke-Schulz
Petra Dirks
Julius C. Eggebrecht
Tjalf Ziemssen

Frontiers in Neurology

doi 10.3389/fneur.2025.1564327

1,373 views

Original Research

Published on 21 May 2025

Long-term outcomes in leucine-rich glioma inactivated-1 autoimmune encephalitis and associated biomarkers of inflammation and neuronal and glial injury

in Multiple Sclerosis and Neuroimmunology

Tyler L. Borko
Phillip Winters
Kelli M. Money
Stefan Sillau
Sadie Eggmann
Sean Selva
Alanna Ritchie
Ryan Kammeyer
Gregory P. Owens
Jeffrey L. Bennett

Frontiers in Neurology

doi 10.3389/fneur.2025.1583892

941 views

Original Research

Published on 21 May 2025

Efgartigimod combined with steroids as a fast-acting therapy for anti-SRP immune-mediated necrotizing myopathy

in Multiple Sclerosis and Neuroimmunology

Qiqi Peng
Xiaoping Yao
Sheng Chen
Xiaofeng Li
Feifei Lin
Zhangyu Zou

Frontiers in Neurology

doi 10.3389/fneur.2025.1560483

747 views

Study Protocol

Published on 16 May 2025

RECLAIM—A retrospective, multicenter observational study aimed at enabling the development of artificial intelligence-driven prognostic models for disease progression in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Jelle Praet
Lina Anderhalten
Giancarlo Comi
Dana Horakova
Tjalf Ziemssen
Patrick Vermersch
Carsten Lukas
Koen Van Leemput
Marjan Steppe
Noemí Manero

Frontiers in Neurology

doi 10.3389/fneur.2025.1557947

1,134 views

Clinical Trial

Published on 09 May 2025

The effects of Leventhal’s self-regulation model-based educational intervention on stress, anxiety, and depression in women with multiple sclerosis: a randomized educational trial

in Multiple Sclerosis and Neuroimmunology

Mahsa Hosseini
Soheila Shamsikhani
Ali Jadidi
Fatemeh Rafiei

Frontiers in Neurology

doi 10.3389/fneur.2025.1521112

821 views

Original Research

Published on 09 May 2025

Immune inflammatory regulation in Anti-NMDAR encephalitis: insights from transcriptome analysis

in Multiple Sclerosis and Neuroimmunology

Shan Qiao
Jia Wang
Shan-chao Zhang
Ai-hua Wang
Hai-yun Li
Tao Xin

Frontiers in Neurology

doi 10.3389/fneur.2025.1568274

896 views

Correction

Published on 08 May 2025

Corrigendum: Dysphagia in multiple sclerosis: pathophysiology, assessment, and management—an overview

in Multiple Sclerosis and Neuroimmunology

Domenico A. Restivo
Angelo Quartarone
Antongiulio Bruschetta
Angelo Alito
Demetrio Milardi
Rosario Marchese-Ragona
Ennio Iezzi
Sheila Peter
Diego Centonze
Mario Stampanoni Bassi

Frontiers in Neurology

doi 10.3389/fneur.2025.1613012

771 views

Original Research

Published on 07 May 2025

Impact of COVID-19 on Guillain Barre Syndrome (GBS) insights from an Iranian referral center

in Multiple Sclerosis and Neuroimmunology

Mohammadali Arami
Rezafarhad Manteghifasaei
Mohammad Karimi
Puya Zandi
Mobina Javadi

Frontiers in Neurology

doi 10.3389/fneur.2025.1565912

968 views

Original Research

Published on 30 Apr 2025

Frequency and risk factors of sleep problems in Egyptian patients with multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Eman M. Khedr
Gellan K. Ahmed
Shady Safwat Hassan
Mohamed Nageh Foly
Motez Mahmoud Attia
Ahmed A. Karim
Nourelhoda A. Haridy

Frontiers in Neurology

doi 10.3389/fneur.2025.1563041

874 views

Original Research

Published on 29 Apr 2025

An expert patient program for people living with multiple sclerosis improves knowledge and empowerment: a pre-test, post-test multicenter implementation study

in Multiple Sclerosis and Neuroimmunology

Miguel Ángel Robles-Sánchez
Paloma Amil-Bujan
Cristina Bosch-Farré
Clàudia Coll-Martínez
María Jesús Arévalo
Elisenda Anglada-Clofent
Rebeca Menéndez-Díaz
Montserrat Aroca-Alsina
Miguel Merchan-Ruiz
Santiago Pérez-Hoyos

Frontiers in Neurology

doi 10.3389/fneur.2025.1581038

1,314 views

Original Research

Published on 28 Apr 2025

Immunotherapy for neuromyelitis optica spectrum disorder: a comparative analysis of efficacy and safety of azathioprine, mycophenolate mofetil, tacrolimus, and rituximab

in Multiple Sclerosis and Neuroimmunology

Jing Zhou
Xiaolin Yang
Xinyi Wang
Bin Li
Yun Xu
Haoran Zhang
Yinxin Zhu
Xiaoming Wang
Jinzhou Feng

Frontiers in Neurology

doi 10.3389/fneur.2025.1559118

1,488 views